Mangoceuticals, Inc.

NasdaqCM:MGRX Stock Report

Market Cap: US$6.8m

Mangoceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:MGRX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Jun 24SellUS$39,834Alexander HamiltonIndividual8,333.34US$4.80

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MGRX?
Owner TypeNumber of SharesOwnership Percentage
Institutions89,5343.6%
Individual Insiders746,66930%
General Public1,650,30966.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 74.1%.

Top Shareholders

Top 19 shareholders own 33.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
24.3%
Jacob Cohen
605,000US$1.6m0%no data
2.68%
Jonathan Arango
66,667US$181.3k0%no data
2.34%
Ackerman Capital Advisors, LLC
58,223US$158.4k0%0.04%
1.54%
Eugene Johnston
38,334US$104.3k188%no data
0.47%
Lorraine D’Alessio
11,667US$31.7k0%no data
0.47%
Kenny Myers
11,667US$31.7k0%no data
0.47%
Amanda Hammer
11,667US$31.7k0%no data
0.35%
Geode Capital Management, LLC
8,755US$23.8k1,810%no data
0.24%
Peak6 Group LLC
5,883US$16.0k-0.1%no data
0.23%
McCollum Christoferson Group, LLC
5,720US$15.6k0%no data
0.1%
Two Sigma Securities, LLC, Asset Management Arm
2,523US$6.9k0%no data
0.084%
Steward Partners Investment Advisory, LLC
2,093US$5.7k0%no data
0.077%
XTX Holdings Limited, Asset Management Arm
1,922US$5.2k0%no data
0.067%
Alexander Hamilton
1,667US$4.5k-50%no data
0.054%
Creative Planning, LLC
1,333US$3.6k0%no data
0.05%
Virtu Financial LLC, Asset Management Arm
1,255US$3.4k-80.9%no data
0.046%
CapFinancial Partners, LLC, Asset Management Arm
1,138US$3.1k0%no data
0.027%
Goldman Sachs Group, Investment Banking and Securities Investments
679US$1.8k0%no data
0.0004%
Bank of America Corporation, Asset Management Arm
10US$27.10%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 01:14
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mangoceuticals, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution